Onkologie

Dienstmann et al.

Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.

2017

Nature reviews. Cancer

Galluzzi et al.

Immunogenic cell death in cancer and infectious disease.

2017

Nature reviews. Immunology

Inadomi

Screening for Colorectal Neoplasia.

2017

The New England journal of medicine

Thiele et al.

Circulating Tumor Cells: Fluid Surrogates of Solid Tumors.

2017

Annual review of pathology

Attard et al.

Prostate cancer.

2016

Lancet

Bracken et al.

A network-biology perspective of microRNA function and dysfunction in cancer.

2016

Nature reviews. Genetics

Cabanillas et al.

Thyroid cancer.

2016

Lancet (London, England)

Capitanio and Montorsi

Renal cancer.

2016

Lancet

Dalerba et al.

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.

2016

N Engl J Med

Deng et al.

Obesity, Inflammation, and Cancer.

2016

Annu Rev Pathol

Elgui de Oliveira et al.

Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.

2016

Trends in microbiology

Feinberg et al.

Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.

2016

Nat Rev Genet

Foulkes et al.

Population genetic testing for cancer susceptibility: founder mutations to genomes.

2016

Nat Rev Clin Oncol

Gabriel et al.

Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.

2016

Clin Chem

Gibney et al.

Predictive biomarkers for checkpoint inhibitor-based immunotherapy.

2016

The Lancet. Oncology

Haji-Ghassemi et al.

Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[β1→4]GlcNAc), by Wisteria floribunda Agglutinin.

2016

The Journal of biological chemistry

Hiley et al.

Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease.

2016

Lancet (London, England)

Hopkins et al.

Obesity and Cancer Mechanisms: Cancer Metabolism.

2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Ifa and Eberlin

Ambient Ionization Mass Spectrometry for Cancer Diagnosis and Surgical Margin Evaluation.

2016

Clin Chem

Iyengar et al.

Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation.

2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Joerger and Fersht

The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.

2016

Annu Rev Biochem

Kalluri

The biology and function of fibroblasts in cancer.

2016

Nature reviews. Cancer

Kamat et al.

Bladder cancer.

2016

Lancet (London, England)

Kamisawa et al.

Pancreatic cancer.

2016

Lancet (London, England)

Khalil et al.

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.

2016

Nat Rev Clin Oncol

León-Mateos et al.

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back.

2016

International journal of molecular sciences

Macintyre et al.

Sequencing Structural Variants in Cancer for Precision Therapeutics.

2016

Trends in genetics : TIG

Matin et al.

MicroRNA Theranostics in Prostate Cancer Precision Medicine.

2016

Clinical chemistry

Mayne et al.

Diet, nutrition, and cancer: past, present and future.

2016

Nature reviews. Clinical oncology

Morice et al.

Endometrial cancer.

2016

Lancet

Nagrath et al.

Opportunities and Challenges for Pancreatic Circulating Tumor Cells.

2016

Gastroenterology

Ng

Iron, microbiota and colorectal cancer

2016

Wiener Medizinische Wochenschrift

Oude Munnink et al.

Therapeutic drug monitoring of monoclonal antibodies in inflammatory and malignant disease: Translating TNF-α experience to oncology.

2016

Clin Pharmacol Ther

Pantel and Alix-Panabières

Functional Studies on Viable Circulating Tumor Cells.

2016

Clin Chem

Parker et al.

Antitumour actions of interferons: implications for cancer therapy.

2016

Nat Rev Cancer

Rajpert-De Meyts et al.

Testicular germ cell tumours.

2016

Lancet

Räsänen et al.

Emerging Roles of SPINK1 in Cancer.

2016

Clin Chem

Roos et al.

DNA damage and the balance between survival and death in cancer biology.

2016

Nat Rev Cancer

Sauzay et al.

Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma.

2016

Clinica chimica acta; international journal of clinical chemistry

Shieh et al.

Population-based screening for cancer: hope and hype.

2016

Nature reviews. Clinical oncology

Steeg

Targeting metastasis.

2016

Nat Rev Cancer

Strum

Colorectal Adenomas.

2016

N Engl J Med

Sur and Taipale

The role of enhancers in cancer.

2016

Nature reviews. Cancer

Swanton and Govindan

Clinical Implications of Genomic Discoveries in Lung Cancer.

2016

N Engl J Med

Tie and Gibbs

Sequencing Circulating Cell-Free DNA: The Potential to Refine Precision Cancer Medicine.

2016

Clin Chem

Topalian et al.

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.

2016

Nat Rev Cancer

Truitt and Ruggero

New frontiers in translational control of the cancer genome.

2016

Nat Rev Cancer

Vargas and Harris

Biomarker development in the precision medicine era: lung cancer as a case study.

2016

Nature reviews. Cancer

Xu et al.

Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.

2016

Critical reviews in clinical laboratory sciences

Zhang et al.

Interleukin-10: An Immune-Activating Cytokine in Cancer Immunotherapy.

2016

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Zhang et al.

A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.

2016

International journal of laboratory hematology

Zhou et al.

Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.

2016

Journal of gastrointestinal cancer

Zhou et al.

Cytokine Signaling in Skeletal Muscle Wasting.

2016

Trends Endocrinol Metab

Zijlstra and Stoorvogel

Prostasomes as a source of diagnostic biomarkers for prostate cancer.

2016

The Journal of clinical investigation

Aggarwal et al.

Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.

2015

Clin Chim Acta

Barber

STING: infection, inflammation and cancer.

2015

Nat Rev Immunol

Baron et al.

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

2015

N Engl J Med

Chalkiadaki and Guarente

The multifaceted functions of sirtuins in cancer.

2015

Nat Rev Cancer

Crusz and Balkwill

Inflammation and cancer: advances and new agents.

2015

Nat Rev Clin Oncol

Di Noto et al.

Polyclonal versus monoclonal immunoglobulin-free light chains quantification.

2015

Annals of clinical biochemistry

Ettl

Genexpressionstests zur Prognose und Prädiktion

2015

Der Gynäkologe

Ferraro et al.

Human epididymis protein 4: factors of variation.

2015

Clin Chim Acta

Filella and Foj

Emerging biomarkers in the detection and prognosis of prostate cancer.

2015

Clin Chem Lab Med

Friedman et al.

Precision medicine for cancer with next-generation functional diagnostics.

2015

Nat Rev Cancer

Hagerling et al.

Balancing the innate immune system in tumor development.

2015

Trends Cell Biol

He et al.

Current State of Circulating MicroRNAs as Cancer Biomarkers.

2015

Clin Chem

Jiang et al.

Autophagy in cellular metabolism and cancer.

2015

J Clin Invest

Khanmi et al.

MicroRNA in prostate cancer.

2015

Clin Chim Acta

Lieben

Diagnosis: RNA-seq for blood-based pan-cancer diagnostics.

2015

Nat Rev Cancer

Lowry et al.

The Role of Exosomes in Breast Cancer.

2015

Clin Chem

Michel et al.

Molekulare Tumortherapie

2015

Internist (Berl)

Neal et al.

Developing biomarker-specific end points in lung cancer clinical trials.

2015

Nat Rev Clin Oncol

Nordgren and Skildum

The deep end of the metabolite pool: influences on epigenetic regulatory mechanisms in cancer.

2015

Eur J Clin Invest

O'Hare et al.

Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.

2015

Expert Rev Cardiovasc Ther

Pinho and Reis

Glycosylation in cancer: mechanisms and clinical implications.

2015

Nat Rev Cancer

Robson et al.

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.

2015

J Clin Oncol

Sanguedolce et al.

Molecular markers in bladder cancer: Novel research frontiers.

2015

Crit Rev Clin Lab Sci

Schwaederle et al.

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.

2015

J Clin Oncol

Seifert et al.

Screening für Krebserkrankungen

2015

Internist (Berl)

Shalapour and Karin

Immunity, inflammation, and cancer: an eternal fight between good and evil.

2015

J Clin Invest

Stoffel

Screening in GI Cancers: The Role of Genetics.

2015

J Clin Oncol

Stowell et al.

Protein glycosylation in cancer.

2015

Annu Rev Pathol

Sundaresan and Haber

Does molecular monitoring matter in early-stage breast cancer?

2015

Sci Transl Med

Tie et al.

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.

2015

Ann Oncol

Van Poznak et al.

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

2015

J Clin Oncol

West et al.

Emerging cytokine networks in colorectal cancer.

2015

Nat Rev Immunol

White

The role for autophagy in cancer.

2015

J Clin Invest

Young and Quirke

Secrets from the microbiome: molecular biology meets microbiology meets histopathology...meets clinical biochemistry.

2015

Annals of clinical biochemistry